Circulating MicroRNAs as Non-Invasive Biomarkers

MicroRNAs in Medicine

Volumn , Issue , 2013, Pages 567-588

  Schwarzenbach, Heidi ^a   Pantel, Klaus ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Circulating nucleic acids; Diagnosis; Exosome; Microvesicle; MiRNA; Non invasive biomarkers; Prenatal

Indexed keywords

EID: 84942306259     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781118300312.ch35     Document Type: Chapter

References (106)

1. Ai, J., R. Zhang, Y. Li, J. Pu, Y. Lu, J. Jiao, K. Li, B. Yu, Z. Li, R. Wang, L. Wang, Q. Li, et al. 2010. Circulating microRNA-1 as a potential novel biomarker for acute myocardial infarction. Biochem Biophys Res Commun 391:73-77.
2. Arroyo, J.D., J.R. Chevillet, E.M. Kroh, I.K. Ruf, C.C. Pritchard, D.F. Gibson, P.S. Mitchell, C.F. Bennett, E.L. Pogosova-Agadjanyan, D.L. Stirewalt, J.F. Tait, and M. Tewari. 2011. Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma. Proc Natl Acad Sci U S A 108:5003-5008.
3. Asaga, S., C. Kuo, T. Nguyen, M. Terpenning, A.E. Giuliano, and D.S. Hoon. 2011. Direct serum assay for microRNA-21 concentrations in early and advanced breast cancer. Clin Chem 57:84-91.
4. Bartel, D.P. 2009. MicroRNAs: target recognition and regulatory functions. Cell 136:215-233.
5. Bommer, G.T., I. Gerin, Y. Feng, A.J. Kaczorowski, R. Kuick, R.E. Love, Y. Zhai, T.J. Giordano, Z.S. Qin, B.B. Moore, O.A. MacDougald, K.R. Cho, et al. 2007. p53-mediated activation of miRNA34 candidate tumor-suppressor genes. Curr Biol 17:1298-1307.
6. Borgono, C.A. and E.P. Diamandis. 2004. The emerging roles of human tissue kallikreins in cancer. Nat Rev Cancer 4:876-890.
7. Brase, J.C., M. Johannes, T. Schlomm, M. Falth, A. Haese, T. Steuber, T. Beissbarth, R. Kuner, and H. Sultmann. 2011. Circulating miRNAs are correlated with tumor progression in prostate cancer. Int J Cancer 128:608-616.
8. Bryant, R.J., T. Pawlowski, J.W. Catto, G. Marsden, R.L. Vessella, B. Rhees, C. Kuslich, T. Visakorpi, and F.C. Hamdy. 2012. Changes in circulating microRNA levels associated with prostate cancer. Br J Cancer 106:768-774.
9. Buccheri, G. and D. Ferrigno. 1988. Usefulness of tissue polypeptide antigen in staging, monitoring, and prognosis of lung cancer. Chest 93:565-570.
10. Burk, U., J. Schubert, U. Wellner, O. Schmalhofer, E. Vincan, S. Spaderna, and T. Brabletz. 2008. A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells. EMBO Rep 9:582-589.
11. Cermelli, S., A. Ruggieri, J.A. Marrero, G.N. Ioannou, and L. Beretta. 2011. Circulating microRNAs in patients with chronic hepatitis C and non-alcoholic fatty liver disease. PLoS ONE 6:e23937.
12. Chen, X., Y. Ba, L. Ma, X. Cai, Y. Yin, K. Wang, J. Guo, Y. Zhang, J. Chen, X. Guo, Q. Li, X. Li, et al. 2008. Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res 18:997-1006.
13. Chen, Z.H., G.L. Zhang, H.R. Li, J.D. Luo, Z.X. Li, G.M. Chen, and J. Yang. 2012. A panel of five circulating microRNAs as potential biomarkers for prostate cancer. Prostate 72:1443-1452.
14. Cheng, H., L. Zhang, D.E. Cogdell, H. Zheng, A.J. Schetter, M. Nykter, C.C. Harris, K. Chen, S.R. Hamilton, and W. Zhang. 2011. Circulating plasma MiR-141 is a novel biomarker for metastatic colon cancer and predicts poor prognosis. PLoS ONE 6:e17745.
15. Cho, W.C. 2012. MicroRNAs as therapeutic targets and their potential applications in cancer therapy. Expert Opin Ther Targets 16:747-759.
16. Chugh, P. and D.P. Dittmer. 2012. Potential pitfalls in microRNA profiling. Wiley Interdiscip Rev RNA 3:601-616.
17. Cocucci, E., G. Racchetti, and J. Meldolesi. 2009. Shedding microvesicles: artefacts no more. Trends Cell Biol 19:43-51.
18. Croce, C.M. 2009. Causes and consequences of microRNA dysregulation in cancer. Nat Rev Genet 10:704-714.
19. Devaux, Y., M. Vausort, E. Goretti, P.V. Nazarov, F. Azuaje, G. Gilson, M.F. Corsten, B. Schroen, M.L. Lair, S. Heymans, and D.R. Wagner. 2012. Use of circulating microRNAs to diagnose acute myocardial infarction. Clin Chem 58:559-567.
20. Duffy, M.J. 1996. Proteases as prognostic markers in cancer. Clin Cancer Res 2:613-618.
21. Emilian, C., E. Goretti, F. Prospert, D. Pouthier, P. Duhoux, G. Gilson, Y. Devaux, and D.R. Wagner. 2012. MicroRNAs in patients on chronic hemodialysis (MINOS study). Clin J Am Soc Nephrol 7:619-623.
22. Esquela-Kerscher, A. and F.J. Slack. 2006. Oncomirs -microRNAs with a role in cancer. Nat Rev Cancer 6:259-269.
23. Fu, Y., Z. Yi, X. Wu, J. Li, and F. Xu. 2011. Circulating microRNAs in patients with active pulmonary tuberculosis. J Clin Microbiol 49:4246-4251.
24. Gallo, A., M. Tandon, I. Alevizos, and G.G. Illei. 2012. The majority of microRNAs detectable in serum and saliva is concentrated in exosomes. PLoS ONE 7:e30679.
25. Grange, C., M. Tapparo, F. Collino, L. Vitillo, C. Damasco, M.C. Deregibus, C. Tetta, B. Bussolati, and G. Camussi. 2011. Microvesicles released from human renal cancer stem cells stimulate angiogenesis and formation of lung premetastatic niche. Cancer Res 71:5346-5356.
26. Guo, H.Q., G.L. Huang, C.C. Guo, X.X. Pu, and T.Y. Lin. 2010. Diagnostic and prognostic value of circulating miR-221 for extranodal natural killer/T-cell lymphoma. Dis Markers 29:251-258.
27. Ha, T.Y. 2011. The role of microRNAs in regulatory T cells and in the immune response. Immune Netw 11:11-41.
28. Heneghan, H.M., N. Miller, and M.J. Kerin. 2010a. Circulating miRNA signatures: promising prognostic tools for cancer. J Clin Oncol 28:e573-e574; author reply e575-e576.
29. Heneghan, H.M., N. Miller, A.J. Lowery, K.J. Sweeney, and M.J. Kerin. 2009. MicroRNAs as novel biomarkers for breast cancer. J Oncol 2009:950201.
30. Heneghan, H.M., N. Miller, A.J. Lowery, K.J. Sweeney, J. Newell, and M.J. Kerin. 2010b. Circulating microRNAs as novel minimally invasive biomarkers for breast cancer. Ann Surg 251:499-505.
31. Howcroft, T.K., H.G. Zhang, M. Dhodapkar, and S. Mohla. 2011. Vesicle transfer and cell fusion: emerging concepts of cell-cell communication in the tumor microenvironment. Cancer Biol Ther 12:159-164.
32. Hu, Z., X. Chen, Y. Zhao, T. Tian, G. Jin, Y. Shu, Y. Chen, L. Xu, K. Zen, C. Zhang, and H. Shen. 2010. Serum microRNA signatures identified in a genome-wide serum microRNA expression profiling predict survival of non-small-cell lung cancer. J Clin Oncol 28:1721-1726.
33. Huang, Z., D. Huang, S. Ni, Z. Peng, W. Sheng, and X. Du. 2010. Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer. Int J Cancer 127:118-126.
34. Hunter, M.P., N. Ismail, X. Zhang, B.D. Aguda, E.J. Lee, L. Yu, T. Xiao, J. Schafer, M.L. Lee, T.D. Schmittgen, S.P. Nana-Sinkam, D. Jarjoura, et al. 2008. Detection of microRNA expression in human peripheral blood microvesicles. PLoS ONE 3:e3694.
35. Hurley, J., D. Roberts, A. Bond, D. Keys, and C. Chen. 2012. Stem-loop RT-qPCR for microRNA expression profiling. Methods Mol Biol 822:33-52.
36. Jung, E.J., L. Santarpia, J. Kim, F.J. Esteva, E. Moretti, A.U. Buzdar, A. Di Leo, X.F. Le, R.C. Bast Jr., S.T. Park, L. Pusztai, and G.A. Calin. 2012. Plasma microRNA 210 levels correlate with sensitivity to trastuzumab and tumor presence in breast cancer patients. Cancer 118:2603-2614.
37. Kanemaru, H., S. Fukushima, J. Yamashita, N. Honda, R. Oyama, A. Kakimoto, S. Masuguchi, T. Ishihara, Y. Inoue, M. Jinnin, and H. Ihn. 2011. The circulating microRNA-221 level in patients with malignant melanoma as a new tumor marker. J Dermatol Sci 61:187-193.
38. Kim, S.H., E.R. Lechman, N. Bianco, R. Menon, A. Keravala, J. Nash, Z. Mi, S.C. Watkins, A. Gambotto, and P.D. Robbins. 2005. Exosomes derived from IL-10-treated dendritic cells can suppress inflammation and collagen-induced arthritis. J Immunol 174:6440-6448.
39. Kim, V.N. 2005. MicroRNA biogenesis: coordinated cropping and dicing. Nat Rev Mol Cell Biol 6:376-385.
40. Komatsu, S., D. Ichikawa, H. Takeshita, M. Tsujiura, R. Morimura, H. Nagata, T. Kosuga, D. Iitaka, H. Konishi, A. Shiozaki, H. Fujiwara, K. Okamoto, et al. 2011. Circulating microRNAs in plasma of patients with oesophageal squamous cell carcinoma. Br J Cancer 105:104-111.
41. Kong, W., H. Yang, L. He, J.J. Zhao, D. Coppola, W.S. Dalton, and J.Q. Cheng. 2008. MicroRNA-155 is regulated by the transforming growth factor beta/Smad pathway and contributes to epithelial cell plasticity by targeting RhoA. Mol Cell Biol 28:6773-6784.
42. Kosaka, N., H. Iguchi, and T. Ochiya. 2010. Circulating microRNA in body fluid: a new potential biomarker for cancer diagnosis and prognosis. Cancer Sci 101:2087-2092.
43. Kroh, E.M., R.K. Parkin, P.S. Mitchell, and M. Tewari. 2010. Analysis of circulating microRNA biomarkers in plasma and serum using quantitative reverse transcription-PCR (qRT-PCR). Methods 50:298-301.
44. Krol, J., I. Loedige, and W. Filipowicz. 2010. The widespread regulation of microRNA biogenesis, function and decay. Nat Rev Genet 11:597-610.
45. Lawrie, C.H., S. Gal, H.M. Dunlop, B. Pushkaran, A.P. Liggins, K. Pulford, A.H. Banham, F. Pezzella, J. Boultwood, J.S. Wainscoat, C.S. Hatton, and A.L. Harris. 2008. Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma. Br J Haematol 141:672-675.
46. Lee, T.H., E. D'Asti, N. Magnus, K. Al-Nedawi, B. Meehan, and J. Rak. 2011. Microvesicles as mediators of intercellular communication in cancer-the emerging science of cellular "debris". Semin Immunopathol 33:455-467.
47. Liu, A.M., T.J. Yao, W. Wang, K.F. Wong, N.P. Lee, S.T. Fan, R.T. Poon, C. Gao, and J.M. Luk. 2012. Circulating miR-15b and miR-130b in serum as potential markers for detecting hepatocellular carcinoma: a retrospective cohort study. BMJ Open 2:e000825.
48. Liu, H., L. Zhu, B. Liu, L. Yang, X. Meng, W. Zhang, Y. Ma, and H. Xiao. 2012. Genome-wide microRNA profiles identify miR-378 as a serum biomarker for early detection of gastric cancer. Cancer Lett 316:196-203.
49. Lo, Y.M. 2012. Fetal nucleic acids in maternal blood: the promises. Clin Chem Lab Med 50:995-998.
50. Lorenzen, J.M., J.T. Kielstein, C. Hafer, S.K. Gupta, P. Kumpers, R. Faulhaber-Walter, H. Haller, D. Fliser, and T. Thum. 2011. Circulating miR-210 predicts survival in critically ill patients with acute kidney injury. Clin J Am Soc Nephrol 6:1540-1546.
51. Ma, L., J. Teruya-Feldstein, and R.A. Weinberg. 2007. Tumour invasion and metastasis initiated by microRNA-10b in breast cancer. Nature 449:682-688.
52. Makino, K., M. Jinnin, I. Kajihara, N. Honda, K. Sakai, S. Masuguchi, S. Fukushima, Y. Inoue, and H. Ihn. 2011. Circulating miR-142-3p levels in patients with systemic sclerosis. Clin Exp Dermatol 37:34-39.
53. McDonald, J.S., D. Milosevic, H.V. Reddi, S.K. Grebe, and A. Algeciras-Schimnich. 2011. Analysis of circulating microRNA: preanalytical and analytical challenges. Clin Chem 57:833-840.
54. Mitchell, P.S., R.K. Parkin, E.M. Kroh, B.R. Fritz, S.K. Wyman, E.L. Pogosova-Agadjanyan, A. Peterson, J. Noteboom, K.C. O'Briant, A. Allen, D.W. Lin, N. Urban, et al. 2008. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci U S A 105:10513-10518.
55. Ng, E.K., W.W. Chong, H. Jin, E.K. Lam, V.Y. Shin, J. Yu, T.C. Poon, S.S. Ng, and J.J. Sung. 2009. Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening. Gut 58:1375-1381.
56. Okada, H., G. Kohanbash, and M.T. Lotze. 2010. MicroRNAs in immune regulation-opportunities for cancer immunotherapy. Int J Biochem Cell Biol 42:1256-1261.
57. Olivieri, F., R. Antonicelli, M. Lorenzi, Y. D'Alessandra, R. Lazzarini, G. Santini, L. Spazzafumo, R. Lisa, L. La Sala, R. Galeazzi, R. Recchioni, R. Testa, et al. 2013. Diagnostic potential of circulating miR-499-5p in elderly patients with acute non ST-elevation myocardial infarction. Int J Cardiol 167:531-536.
58. Paraskevi, A., G. Theodoropoulos, I. Papaconstantinou, G. Mantzaris, N. Nikiteas, and M. Gazouli. 2012. Circulating MicroRNA in inflammatory bowel disease. J Crohns Colitis 6:900-904.
59. Pegtel, D.M., K. Cosmopoulos, D.A. Thorley-Lawson, M.A. van Eijndhoven, E.S. Hopmans, J.L. Lindenberg, T.D. de Gruijl, T. Wurdinger, and J.M. Middeldorp. 2010. Functional delivery of viral miRNAs via exosomes. Proc Natl Acad Sci U S A 107:6328-6333.
60. Qi, P., S.Q. Cheng, H. Wang, N. Li, Y.F. Chen, and C.F. Gao. 2011. Serum microRNAs as biomarkers for hepatocellular carcinoma in Chinese patients with chronic hepatitis B virus infection. PLoS ONE 6:e28486.
61. Qu, K.Z., K. Zhang, H. Li, N.H. Afdhal, and M. Albitar. 2011. Circulating microRNAs as biomarkers for hepatocellular carcinoma. J Clin Gastroenterol 45:355-360.
62. Roth, C., B. Rack, V. Muller, W. Janni, K. Pantel, and H. Schwarzenbach. 2010. Circulating microRNAs as blood-based markers for patients with primary and metastatic breast cancer. Breast Cancer Res 12:R90.
63. Roth, C., S. Kasimir-Bauer, M. Heubner, K. Pantel, and H. Schwarzenbach. 2011a. Increase in circulating microRNA levels in blood of ovarian cancer patients. In Circulating nucleic acids in plasma and serum. P.B. Gahan, Ed. Springer.
64. Roth, C., S. Kasimir-Bauer, K. Pantel, and H. Schwarzenbach. 2011b. Screening for circulating nucleic acids and caspase activity in the peripheral blood as potential diagnostic tools in lung cancer. Mol Oncol 5:281-291.
65. Schaefer, A., M. Jung, K. Miller, M. Lein, G. Kristiansen, A. Erbersdobler, and K. Jung. 2010. Suitable reference genes for relative quantification of miRNA expression in prostate cancer. Exp Mol Med 42:749-758.
66. Schwarzenbach, H., D.S. Hoon, and K. Pantel. 2011. Cell-free nucleic acids as biomarkers in cancer patients. Nat Rev Cancer 11:426-437.
67. Schwarzenbach, H., K. Milde-Langosch, B. Steinbach, V. Muller, and K. Pantel. 2012. Diagnostic potential of PTEN-targeting miR-214 in the blood of breast cancer patients. Breast Cancer Res Treat 134:933-941.
68. Shen, J., G.W. Hruby, J.M. McKiernan, I. Gurvich, M.J. Lipsky, M.C. Benson, and R.M. Santella. 2012. Dysregulation of circulating microRNAs and prediction of aggressive prostate cancer. Prostate 72:1469-1477.
69. Shen, J., Z. Liu, N.W. Todd, H. Zhang, J. Liao, L. Yu, M.A. Guarnera, R. Li, L. Cai, M. Zhan, and F. Jiang. 2011. Diagnosis of lung cancer in individuals with solitary pulmonary nodules by plasma microRNA biomarkers. BMC Cancer 11:374.
70. Silva, J., V. Garcia, A. Zaballos, M. Provencio, L. Lombardia, L. Almonacid, J.M. Garcia, G. Dominguez, C. Pena, R. Diaz, M. Herrera, A. Varela, et al. 2011. Vesicle-related microRNAs in plasma of NSCLC patients and correlation with survival. Eur Respir J 37:617-623.
71. Song, J., Z. Bai, W. Han, J. Zhang, H. Meng, J. Bi, X. Ma, S. Han, and Z. Zhang. 2012. Identification of suitable reference genes for qPCR analysis of serum microRNA in gastric cancer patients. Dig Dis Sci 57:897-904.
72. Starkey Lewis, P.J., J. Dear, V. Platt, K.J. Simpson, D.G. Craig, D.J. Antoine, N.S. French, N. Dhaun, D.J. Webb, E.M. Costello, J.P. Neoptolemos, J. Moggs, et al. 2011. Circulating microRNAs as potential markers of human drug-induced liver injury. Hepatology 54:1767-1776.
73. Stroun, M., J. Lyautey, C. Lederrey, A. Olson-Sand, and P. Anker. 2001. About the possible origin and mechanism of circulating DNA apoptosis and active DNA release. Clin Chim Acta 313:139-142.
74. Tanaka, M., K. Oikawa, M. Takanashi, M. Kudo, J. Ohyashiki, K. Ohyashiki, and M. Kuroda. 2009. Down-regulation of miR-92 in human plasma is a novel marker for acute leukemia patients. PLoS ONE 4:e5532.
75. Taylor, D.D. and C. Gercel-Taylor. 2008. MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer. Gynecol Oncol 110:13-21.
76. Toffanin, S., D. Sia, and A. Villanueva. 2012. microRNAs: new ways to block tumor angiogenesis? J Hepatol 57:490-491.
77. Tomimaru, Y., H. Eguchi, H. Nagano, H. Wada, S. Kobayashi, S. Marubashi, M. Tanemura, A. Tomokuni, I. Takemasa, K. Umeshita, T. Kanto, Y. Doki, et al. 2012. Circulating microRNA-21 as a novel biomarker for hepatocellular carcinoma. J Hepatol 56:167-175.
78. Tsai, K.W., Y.L. Liao, C.W. Wu, L.Y. Hu, S.C. Li, W.C. Chan, M.R. Ho, C.H. Lai, H.W. Kao, W.L. Fang, K.H. Huang, and W.C. Lin. 2012. Aberrant expression of miR-196a in gastric cancers and correlation with recurrence. Genes Chromosomes Cancer 51:394-401.
79. Tsujiura, M., D. Ichikawa, S. Komatsu, A. Shiozaki, H. Takeshita, T. Kosuga, H. Konishi, R. Morimura, K. Deguchi, H. Fujiwara, K. Okamoto, and E. Otsuji. 2010. Circulating microRNAs in plasma of patients with gastric cancers. Br J Cancer 102:1174-1179.
80. Turchinovich, A., L. Weiz, A. Langheinz, and B. Burwinkel. 2011. Characterization of extracellular circulating microRNA. Nucleic Acids Res 39:7223-7233.
81. Valadi, H., K. Ekstrom, A. Bossios, M. Sjostrand, J.J. Lee, and J.O. Lotvall. 2007. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol 9:654-659.
82. Valenti, R., V. Huber, P. Filipazzi, L. Pilla, G. Sovena, A. Villa, A. Corbelli, S. Fais, G. Parmiani, and L. Rivoltini. 2006. Human tumor-released microvesicles promote the differentiation of myeloid cells with transforming growth factor-beta-mediated suppressive activity on T lymphocytes. Cancer Res 66:9290-9298.
83. van Schooneveld, E., M.C. Wouters, I. Van der Auwera, D.J. Peeters, H. Wildiers, P.A. Van Dam, I. Vergote, P.B. Vermeulen, L.Y. Dirix, and S.J. Van Laere. 2012. Expression profiling of cancerous and normal breast tissues identifies microRNAs that are differentially expressed in serum from patients with (metastatic) breast cancer and healthy volunteers. Breast Cancer Res 14:R34.
84. Vickers, K.C. and A.T. Remaley. 2012. Lipid-based carriers of microRNAs and intercellular communication. Curr Opin Lipidol 23:91-97.
85. Wang, F., Z. Zheng, J. Guo, and X. Ding. 2010. Correlation and quantitation of microRNA aberrant expression in tissues and sera from patients with breast tumor. Gynecol Oncol 119:586-593.
86. Wang, G., L.S. Tam, E.K. Li, B.C. Kwan, K.M. Chow, C.C. Luk, P.K. Li, and C.C. Szeto. 2011. Serum and urinary free microRNA level in patients with systemic lupus erythematosus. Lupus 20:493-500.
87. Wang, J.F., M.L. Yu, G. Yu, J.J. Bian, X.M. Deng, X.J. Wan, and K.M. Zhu. 2010. Serum miR-146a and miR-223 as potential new biomarkers for sepsis. Biochem Biophys Res Commun 394:184-188.
88. Wang, L.G. and J. Gu. 2012. Serum microRNA-29a is a promising novel marker for early detection of colorectal liver metastasis. Cancer Epidemiol 36:e61-e67.
89. Wang, M., H. Gu, S. Wang, H. Qian, W. Zhu, L. Zhang, C. Zhao, Y. Tao, and W. Xu. 2012. Circulating miR-17-5p and miR-20a: molecular markers for gastric cancer. Mol Med Rep 5:1514-1520.
90. Wang, R., N. Li, Y. Zhang, Y. Ran, and J. Pu. 2011. Circulating MicroRNAs are promising novel biomarkers of acute myocardial infarction. Intern Med 50:1789-1795.
91. Wang, Y., D. Zheng, Q. Tan, M.X. Wang, and L.Q. Gu. 2011. Nanopore-based detection of circulating microRNAs in lung cancer patients. Nat Nanotechnol 6:668-674.
92. Wei, J., W. Gao, C.J. Zhu, Y.Q. Liu, Z. Mei, T. Cheng, and Y.Q. Shu. 2011. Identification of plasma microRNA-21 as a biomarker for early detection and chemosensitivity of non-small cell lung cancer. Chin J Cancer 30:407-414.
93. Widera, C., S.K. Gupta, J.M. Lorenzen, C. Bang, J. Bauersachs, K. Bethmann, T. Kempf, K.C. Wollert, and T. Thum. 2011. Diagnostic and prognostic impact of six circulating microRNAs in acute coronary syndrome. J Mol Cell Cardiol 51:872-875.
94. Wu, F., N.J. Guo, H. Tian, M. Marohn, S. Gearhart, T.M. Bayless, S.R. Brant, and J.H. Kwon. 2011. Peripheral blood microRNAs distinguish active ulcerative colitis and Crohn's disease. Inflamm Bowel Dis 17:241-250.
95. Wu, X., G. Somlo, Y. Yu, M.R. Palomares, A.X. Li, W. Zhou, A. Chow, Y. Yen, J.J. Rossi, H. Gao, J. Wang, Y.C. Yuan, et al. 2012. De novo sequencing of circulating miRNAs identifies novel markers predicting clinical outcome of locally advanced breast cancer. J Transl Med 10:42.
96. Xu, J., C. Wu, X. Che, L. Wang, D. Yu, T. Zhang, L. Huang, H. Li, W. Tan, C. Wang, and D. Lin. 2011. Circulating microRNAs, miR-21, miR-122, and miR-223, in patients with hepatocellular carcinoma or chronic hepatitis. Mol Carcinog 50:136-142.
97. Yaman Agaoglu, F., M. Kovancilar, Y. Dizdar, E. Darendeliler, S. Holdenrieder, N. Dalay, and U. Gezer. 2011. Investigation of miR-21, miR-141, and miR-221 in blood circulation of patients with prostate cancer. Tumour Biol 32:583-588.
98. Yang, M., J. Chen, F. Su, B. Yu, L. Lin, Y. Liu, J.D. Huang, and E. Song. 2011. Microvesicles secreted by macrophages shuttle invasion-potentiating microRNAs into breast cancer cells. Mol Cancer 10:117.
99. Yu, J., Y. Wang, R. Dong, X. Huang, S. Ding, and H. Qiu. 2012. Circulating microRNA-218 was reduced in cervical cancer and correlated with tumor invasion. J Cancer Res Clin Oncol 138:671-674.
100. Zampetaki, A., S. Kiechl, I. Drozdov, P. Willeit, U. Mayr, M. Prokopi, A. Mayr, S. Weger, F. Oberhollenzer, E. Bonora, A. Shah, J. Willeit, et al. 2010. Plasma microRNA profiling reveals loss of endothelial miR-126 and other microRNAs in type 2 diabetes. Circ Res 107:810-817.
101. Zhang, H.L., L.F. Yang, Y. Zhu, X.D. Yao, S.L. Zhang, B. Dai, Y.P. Zhu, Y.J. Shen, G.H. Shi, and D.W. Ye. 2011. Serum miRNA-21: Elevated levels in patients with metastatic hormone-refractory prostate cancer and potential predictive factor for the efficacy of docetaxel-based chemotherapy. Prostate 71:326-331.
102. Zhang, Y., Y. Jia, R. Zheng, Y. Guo, Y. Wang, H. Guo, M. Fei, and S. Sun. 2010. Plasma microRNA-122 as a biomarker for viral-, alcohol-, and chemical-related hepatic diseases. Clin Chem 56:1830-1838.
103. Zhao, Z., Q. Zhao, J. Warrick, C.M. Lockwood, A. Woodworth, K.H. Moley, and A.M. Gronowski. 2012. Circulating microRNA miR-323-3p as a biomarker of ectopic pregnancy. Clin Chem 58:896-905.
104. Zheng, D., S. Haddadin, Y. Wang, L.Q. Gu, M.C. Perry, C.E. Freter, and M.X. Wang. 2011. Plasma microRNAs as novel biomarkers for early detection of lung cancer. Int J Clin Exp Pathol 4:575-586.
105. Zhou, H., J.M. Guo, Y.R. Lou, X.J. Zhang, F.D. Zhong, Z. Jiang, J. Cheng, and B.X. Xiao. 2010. Detection of circulating tumor cells in peripheral blood from patients with gastric cancer using microRNA as a marker. J Mol Med (Berl) 88:709-717.
106. Zuo, Z., G.A. Calin, H.M. de Paula, L.J. Medeiros, M.H. Fernandez, M. Shimizu, G. Garcia-Manero, and C.E. Bueso-Ramos. 2011. Circulating microRNAs let-7a and miR-16 predict progression-free survival and overall survival in patients with myelodysplastic syndrome. Blood 118:413-415.